Imagin Medical Inc C.IME

Alternate Symbol(s): IMEXF

Technology Diagnostics & Research Scientific & Technical Instruments

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.

CSE:IME - Post by User

Imagin Medical Inc

Bullboard Posts

Comment by coty1940on Oct 23, 2017 1:01pm

55 Views

Post# 26845512

RE:very nice folks...this says everything!

The small player in the group is gaining interest for its new, patented technology for use in medical imaging targeting bladder cancer. Imagin Medical Inc., (CSE: IME) (OTC: IMEXF) is heading into human testing with its i/Blue™ cancer imaging technology and offers major promise for that dread disease.

Bullboard Posts

Global Tungsten Market and Supply Security